Back

Beyond the ECG: a systematic review on the emerging importance of subclinical atrial fibrillation in patients with sarcomeric and non-sarcomeric hcm and with cardiac amyloidosis.

29 August 2025 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (1) - Hypertrophic cardiomyopathy Hypertrophic Cardiomyopathy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Salvatore Di Napoli

Federico II University Hospital, Napoly (Italy)

10 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor I. Cergan (Bucharest, RO)
Abstract Slides Video
Presentation thumbnail
Mr L. Puglla Sanchez (Zaragoza, ES)
Abstract Slides Video
Presentation thumbnail
Doctor K. Fragkiadakis (Heraklion, GR)
Abstract Slides Video
Presentation thumbnail
Doctor C. Mann (Vienna, AT)
Abstract

Access the full session

Session thumbnail
New perspectives in cardiology (1) - Hypertrophic cardiomyopathy

The Event

Event poster

ESC Congress 2025

29 August 2025 12:30 CET
You may be interested in
thumbnail
Congress Presentation
Incidence and clinical implications of de novo clinical and subclinical atrial fibrillation in implantable cardioverter-defibrillator recipients with ischemic or non-ischemic cardiomyopathy
thumbnail
Congress Presentation
Trends in prevalence and clinical outcomes of patients with atrial fibrillation and cardiac amyloidosis- from a nationwide registry
thumbnail
Congress Session
Atrial fibrillation miscellaneous

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources